[
  {
    "text": "1.20 \"Claim\" has the meaning set forth in Section 13.1..",
    "bbox": [
      111,
      83,
      512,
      94
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.21 \"Clinical Trial' means any human clinical study or trial of a Licensed Product in the Field in the Territory..",
    "bbox": [
      110,
      113,
      917,
      127
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.22 \"Combination Product\"' means a product that is Commercialized by Vyera and/or its Affiliates under this Agreement and that comprises, consists of,",
    "bbox": [
      110,
      145,
      1000,
      157
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "or incorporates two or more APIs (whether administered together or separately), which includes leronlimab as one of the APIs together with one or more",
    "bbox": [
      111,
      161,
      1000,
      173
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "additional APIs that: (a) are not leronlimab; and (b) are not proprietary to CytoDyn, regardless of the formulation or mode of administration of such",
    "bbox": [
      111,
      176,
      1000,
      188
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Combination Product. For the sake of clarity, a Combination Product is a Licensed Product.",
    "bbox": [
      112,
      193,
      770,
      203
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.23 \"Commercial Failure' means that Vyera fails to achieve aggregate [***].",
    "bbox": [
      110,
      221,
      681,
      236
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.24 \"Commercialization' means any and all pre-launch, launch and post-launch activities related to the marketing, promoting, distributing (to Third",
    "bbox": [
      112,
      254,
      1000,
      266
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Parties), offering for sale and selling a Licensed Product in the Field in the Territory. For clarity, Commercialization does not include Development and/or",
    "bbox": [
      111,
      270,
      1000,
      282
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Manufacturing of a Licensed Product. When used as a verb, \"Commercialize\" means to engage in Commercialization..",
    "bbox": [
      111,
      285,
      972,
      297
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.25 \"Commercialization Plan\"' has the meaning set forth in Section 5.2.",
    "bbox": [
      111,
      316,
      638,
      328
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.26 \"Commercially Reasonable Efforts\"' means: (a) with respect to the efforts to be expended, or considerations to be undertaken, by a Party or its",
    "bbox": [
      112,
      348,
      1000,
      358
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Affiliate with respect to any objective, activity or decision to be undertaken hereunder, reasonable, good faith efforts to accomplish such objective,",
    "bbox": [
      112,
      363,
      1000,
      375
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "activity or decision as such Party would normally use to accomplish a similar objective, activity or decision under similar circumstances; and (b) with",
    "bbox": [
      112,
      379,
      1000,
      390
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "respect to Development and Commercialization of any Licensed Product for any indication by a Party, efforts and resources consistent with those efforts",
    "bbox": [
      110,
      393,
      1000,
      406
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "and resources commonly used by a similarly situated biotechnology company with respect to a product owned by it or to which it has similar rights,",
    "bbox": [
      111,
      409,
      1000,
      421
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "which product is at a similar stage in its development or product life and is of similar market potential taking into account (i) the patent and other",
    "bbox": [
      112,
      425,
      1000,
      437
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "proprietary position of the Licensed Product and (ii) the anticipated profitability of the Licensed Product..",
    "bbox": [
      111,
      440,
      875,
      453
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.27 \"Competitive Product' means any product for the treatment or prevention of [***], leronlimab that is not a Licensed Product..",
    "bbox": [
      111,
      471,
      1000,
      483
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.28 \"Confidential Information\"' means, subject to Article 10, all non-public or proprietary information not otherwise included in Know-How disclosed by.",
    "bbox": [
      111,
      502,
      1000,
      514
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "either Party to the other Party in connection with the activities contemplated by this Agreement, which may include ideas, inventions, discoveries,",
    "bbox": [
      111,
      518,
      1000,
      530
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "concepts, compounds, compositions, formulations, formulas, practices, procedures, processes, methods, knowledge, know-how, trade secrets,.",
    "bbox": [
      111,
      534,
      1000,
      545
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "technology, inventories, machines, techniques, development, designs, drawings, computer programs, knowledge, skill, experience, documents, apparatus,",
    "bbox": [
      110,
      548,
      1000,
      562
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "results, clinical and regulatory strategies, Regulatory Documentation, and submissions pertaining to, or made in association with, filings with any",
    "bbox": [
      110,
      564,
      1000,
      577
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Governmental Authority, data, including pharmacological, toxicological and clinical data, analytical and quality control data, manufacturing data and",
    "bbox": [
      112,
      581,
      1000,
      591
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "descriptions, patent and legal data, market data, financial data or descriptions, devices, assays, chemical formulations, specifications, material, product",
    "bbox": [
      112,
      597,
      1000,
      607
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "samples and other samples, physical, chemical and biological materials and compounds and information related to such materials and compounds, and",
    "bbox": [
      111,
      611,
      1000,
      623
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "any modifications, improvements, designs, and recipes without regard as to whether any of the foregoing is marked \"confidential' or \"proprietary,\" or",
    "bbox": [
      111,
      627,
      1000,
      640
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "disclosed in oral, written, graphic, or electronic form. Confidential Information shall include the terms and conditions of this Agreement..",
    "bbox": [
      110,
      642,
      1000,
      655
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Source: CYTODYN INC., 10-Q, 1/9/2020",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.20 \"Claim\" has the meaning set forth in Section 13.1..",
    "bbox": [
      111,
      83,
      512,
      94
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.21 \"Clinical Trial' means any human clinical study or trial of a Licensed Product in the Field in the Territory..",
    "bbox": [
      110,
      113,
      917,
      127
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.22 \"Combination Product\"' means a product that is Commercialized by Vyera and/or its Affiliates under this Agreement and that comprises, consists of,",
    "bbox": [
      110,
      145,
      1000,
      157
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "or incorporates two or more APIs (whether administered together or separately), which includes leronlimab as one of the APIs together with one or more",
    "bbox": [
      111,
      161,
      1000,
      173
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "additional APIs that: (a) are not leronlimab; and (b) are not proprietary to CytoDyn, regardless of the formulation or mode of administration of such",
    "bbox": [
      111,
      176,
      1000,
      188
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Combination Product. For the sake of clarity, a Combination Product is a Licensed Product.",
    "bbox": [
      112,
      193,
      770,
      203
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.23 \"Commercial Failure' means that Vyera fails to achieve aggregate [***].",
    "bbox": [
      110,
      221,
      681,
      236
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.24 \"Commercialization' means any and all pre-launch, launch and post-launch activities related to the marketing, promoting, distributing (to Third",
    "bbox": [
      112,
      254,
      1000,
      266
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Parties), offering for sale and selling a Licensed Product in the Field in the Territory. For clarity, Commercialization does not include Development and/or",
    "bbox": [
      111,
      270,
      1000,
      282
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Manufacturing of a Licensed Product. When used as a verb, \"Commercialize\" means to engage in Commercialization..",
    "bbox": [
      111,
      285,
      972,
      297
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.25 \"Commercialization Plan\"' has the meaning set forth in Section 5.2.",
    "bbox": [
      111,
      316,
      638,
      328
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.26 \"Commercially Reasonable Efforts\"' means: (a) with respect to the efforts to be expended, or considerations to be undertaken, by a Party or its",
    "bbox": [
      112,
      348,
      1000,
      358
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Affiliate with respect to any objective, activity or decision to be undertaken hereunder, reasonable, good faith efforts to accomplish such objective,",
    "bbox": [
      112,
      363,
      1000,
      375
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "activity or decision as such Party would normally use to accomplish a similar objective, activity or decision under similar circumstances; and (b) with",
    "bbox": [
      112,
      379,
      1000,
      390
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "respect to Development and Commercialization of any Licensed Product for any indication by a Party, efforts and resources consistent with those efforts",
    "bbox": [
      110,
      393,
      1000,
      406
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "and resources commonly used by a similarly situated biotechnology company with respect to a product owned by it or to which it has similar rights,",
    "bbox": [
      111,
      409,
      1000,
      421
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "which product is at a similar stage in its development or product life and is of similar market potential taking into account (i) the patent and other",
    "bbox": [
      112,
      425,
      1000,
      437
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "proprietary position of the Licensed Product and (ii) the anticipated profitability of the Licensed Product..",
    "bbox": [
      111,
      440,
      875,
      453
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.27 \"Competitive Product' means any product for the treatment or prevention of [***], leronlimab that is not a Licensed Product..",
    "bbox": [
      111,
      471,
      1000,
      483
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.28 \"Confidential Information\"' means, subject to Article 10, all non-public or proprietary information not otherwise included in Know-How disclosed by.",
    "bbox": [
      111,
      502,
      1000,
      514
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "either Party to the other Party in connection with the activities contemplated by this Agreement, which may include ideas, inventions, discoveries,",
    "bbox": [
      111,
      518,
      1000,
      530
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "concepts, compounds, compositions, formulations, formulas, practices, procedures, processes, methods, knowledge, know-how, trade secrets,.",
    "bbox": [
      111,
      534,
      1000,
      545
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "technology, inventories, machines, techniques, development, designs, drawings, computer programs, knowledge, skill, experience, documents, apparatus,",
    "bbox": [
      110,
      548,
      1000,
      562
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "results, clinical and regulatory strategies, Regulatory Documentation, and submissions pertaining to, or made in association with, filings with any",
    "bbox": [
      110,
      564,
      1000,
      577
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Governmental Authority, data, including pharmacological, toxicological and clinical data, analytical and quality control data, manufacturing data and",
    "bbox": [
      112,
      581,
      1000,
      591
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "descriptions, patent and legal data, market data, financial data or descriptions, devices, assays, chemical formulations, specifications, material, product",
    "bbox": [
      112,
      597,
      1000,
      607
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "samples and other samples, physical, chemical and biological materials and compounds and information related to such materials and compounds, and",
    "bbox": [
      111,
      611,
      1000,
      623
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "any modifications, improvements, designs, and recipes without regard as to whether any of the foregoing is marked \"confidential' or \"proprietary,\" or",
    "bbox": [
      111,
      627,
      1000,
      640
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "disclosed in oral, written, graphic, or electronic form. Confidential Information shall include the terms and conditions of this Agreement..",
    "bbox": [
      110,
      642,
      1000,
      655
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "Source: CYTODYN INC., 10-Q, 1/9/2020",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 11,
    "category": "Exclusivity"
  },
  {
    "text": "1.20 \"Claim\" has the meaning set forth in Section 13.1..",
    "bbox": [
      111,
      83,
      512,
      94
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.21 \"Clinical Trial' means any human clinical study or trial of a Licensed Product in the Field in the Territory..",
    "bbox": [
      110,
      113,
      917,
      127
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.22 \"Combination Product\"' means a product that is Commercialized by Vyera and/or its Affiliates under this Agreement and that comprises, consists of,",
    "bbox": [
      110,
      145,
      1000,
      157
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "or incorporates two or more APIs (whether administered together or separately), which includes leronlimab as one of the APIs together with one or more",
    "bbox": [
      111,
      161,
      1000,
      173
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "additional APIs that: (a) are not leronlimab; and (b) are not proprietary to CytoDyn, regardless of the formulation or mode of administration of such",
    "bbox": [
      111,
      176,
      1000,
      188
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Combination Product. For the sake of clarity, a Combination Product is a Licensed Product.",
    "bbox": [
      112,
      193,
      770,
      203
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.23 \"Commercial Failure' means that Vyera fails to achieve aggregate [***].",
    "bbox": [
      110,
      221,
      681,
      236
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.24 \"Commercialization' means any and all pre-launch, launch and post-launch activities related to the marketing, promoting, distributing (to Third",
    "bbox": [
      112,
      254,
      1000,
      266
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Parties), offering for sale and selling a Licensed Product in the Field in the Territory. For clarity, Commercialization does not include Development and/or",
    "bbox": [
      111,
      270,
      1000,
      282
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Manufacturing of a Licensed Product. When used as a verb, \"Commercialize\" means to engage in Commercialization..",
    "bbox": [
      111,
      285,
      972,
      297
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.25 \"Commercialization Plan\"' has the meaning set forth in Section 5.2.",
    "bbox": [
      111,
      316,
      638,
      328
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.26 \"Commercially Reasonable Efforts\"' means: (a) with respect to the efforts to be expended, or considerations to be undertaken, by a Party or its",
    "bbox": [
      112,
      348,
      1000,
      358
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Affiliate with respect to any objective, activity or decision to be undertaken hereunder, reasonable, good faith efforts to accomplish such objective,",
    "bbox": [
      112,
      363,
      1000,
      375
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "activity or decision as such Party would normally use to accomplish a similar objective, activity or decision under similar circumstances; and (b) with",
    "bbox": [
      112,
      379,
      1000,
      390
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "respect to Development and Commercialization of any Licensed Product for any indication by a Party, efforts and resources consistent with those efforts",
    "bbox": [
      110,
      393,
      1000,
      406
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "and resources commonly used by a similarly situated biotechnology company with respect to a product owned by it or to which it has similar rights,",
    "bbox": [
      111,
      409,
      1000,
      421
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "which product is at a similar stage in its development or product life and is of similar market potential taking into account (i) the patent and other",
    "bbox": [
      112,
      425,
      1000,
      437
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "proprietary position of the Licensed Product and (ii) the anticipated profitability of the Licensed Product..",
    "bbox": [
      111,
      440,
      875,
      453
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.27 \"Competitive Product' means any product for the treatment or prevention of [***], leronlimab that is not a Licensed Product..",
    "bbox": [
      111,
      471,
      1000,
      483
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.28 \"Confidential Information\"' means, subject to Article 10, all non-public or proprietary information not otherwise included in Know-How disclosed by.",
    "bbox": [
      111,
      502,
      1000,
      514
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "either Party to the other Party in connection with the activities contemplated by this Agreement, which may include ideas, inventions, discoveries,",
    "bbox": [
      111,
      518,
      1000,
      530
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "concepts, compounds, compositions, formulations, formulas, practices, procedures, processes, methods, knowledge, know-how, trade secrets,.",
    "bbox": [
      111,
      534,
      1000,
      545
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "technology, inventories, machines, techniques, development, designs, drawings, computer programs, knowledge, skill, experience, documents, apparatus,",
    "bbox": [
      110,
      548,
      1000,
      562
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "results, clinical and regulatory strategies, Regulatory Documentation, and submissions pertaining to, or made in association with, filings with any",
    "bbox": [
      110,
      564,
      1000,
      577
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Governmental Authority, data, including pharmacological, toxicological and clinical data, analytical and quality control data, manufacturing data and",
    "bbox": [
      112,
      581,
      1000,
      591
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "descriptions, patent and legal data, market data, financial data or descriptions, devices, assays, chemical formulations, specifications, material, product",
    "bbox": [
      112,
      597,
      1000,
      607
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "samples and other samples, physical, chemical and biological materials and compounds and information related to such materials and compounds, and",
    "bbox": [
      111,
      611,
      1000,
      623
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "any modifications, improvements, designs, and recipes without regard as to whether any of the foregoing is marked \"confidential' or \"proprietary,\" or",
    "bbox": [
      111,
      627,
      1000,
      640
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "disclosed in oral, written, graphic, or electronic form. Confidential Information shall include the terms and conditions of this Agreement..",
    "bbox": [
      110,
      642,
      1000,
      655
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Source: CYTODYN INC., 10-Q, 1/9/2020",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.20 \"Claim\" has the meaning set forth in Section 13.1..",
    "bbox": [
      111,
      83,
      512,
      94
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.21 \"Clinical Trial' means any human clinical study or trial of a Licensed Product in the Field in the Territory..",
    "bbox": [
      110,
      113,
      917,
      127
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.22 \"Combination Product\"' means a product that is Commercialized by Vyera and/or its Affiliates under this Agreement and that comprises, consists of,",
    "bbox": [
      110,
      145,
      1000,
      157
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "or incorporates two or more APIs (whether administered together or separately), which includes leronlimab as one of the APIs together with one or more",
    "bbox": [
      111,
      161,
      1000,
      173
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "additional APIs that: (a) are not leronlimab; and (b) are not proprietary to CytoDyn, regardless of the formulation or mode of administration of such",
    "bbox": [
      111,
      176,
      1000,
      188
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Combination Product. For the sake of clarity, a Combination Product is a Licensed Product.",
    "bbox": [
      112,
      193,
      770,
      203
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.23 \"Commercial Failure' means that Vyera fails to achieve aggregate [***].",
    "bbox": [
      110,
      221,
      681,
      236
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.24 \"Commercialization' means any and all pre-launch, launch and post-launch activities related to the marketing, promoting, distributing (to Third",
    "bbox": [
      112,
      254,
      1000,
      266
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Parties), offering for sale and selling a Licensed Product in the Field in the Territory. For clarity, Commercialization does not include Development and/or",
    "bbox": [
      111,
      270,
      1000,
      282
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Manufacturing of a Licensed Product. When used as a verb, \"Commercialize\" means to engage in Commercialization..",
    "bbox": [
      111,
      285,
      972,
      297
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.25 \"Commercialization Plan\"' has the meaning set forth in Section 5.2.",
    "bbox": [
      111,
      316,
      638,
      328
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.26 \"Commercially Reasonable Efforts\"' means: (a) with respect to the efforts to be expended, or considerations to be undertaken, by a Party or its",
    "bbox": [
      112,
      348,
      1000,
      358
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Affiliate with respect to any objective, activity or decision to be undertaken hereunder, reasonable, good faith efforts to accomplish such objective,",
    "bbox": [
      112,
      363,
      1000,
      375
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "activity or decision as such Party would normally use to accomplish a similar objective, activity or decision under similar circumstances; and (b) with",
    "bbox": [
      112,
      379,
      1000,
      390
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "respect to Development and Commercialization of any Licensed Product for any indication by a Party, efforts and resources consistent with those efforts",
    "bbox": [
      110,
      393,
      1000,
      406
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "and resources commonly used by a similarly situated biotechnology company with respect to a product owned by it or to which it has similar rights,",
    "bbox": [
      111,
      409,
      1000,
      421
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "which product is at a similar stage in its development or product life and is of similar market potential taking into account (i) the patent and other",
    "bbox": [
      112,
      425,
      1000,
      437
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "proprietary position of the Licensed Product and (ii) the anticipated profitability of the Licensed Product..",
    "bbox": [
      111,
      440,
      875,
      453
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.27 \"Competitive Product' means any product for the treatment or prevention of [***], leronlimab that is not a Licensed Product..",
    "bbox": [
      111,
      471,
      1000,
      483
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.28 \"Confidential Information\"' means, subject to Article 10, all non-public or proprietary information not otherwise included in Know-How disclosed by.",
    "bbox": [
      111,
      502,
      1000,
      514
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "either Party to the other Party in connection with the activities contemplated by this Agreement, which may include ideas, inventions, discoveries,",
    "bbox": [
      111,
      518,
      1000,
      530
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "concepts, compounds, compositions, formulations, formulas, practices, procedures, processes, methods, knowledge, know-how, trade secrets,.",
    "bbox": [
      111,
      534,
      1000,
      545
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "technology, inventories, machines, techniques, development, designs, drawings, computer programs, knowledge, skill, experience, documents, apparatus,",
    "bbox": [
      110,
      548,
      1000,
      562
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "results, clinical and regulatory strategies, Regulatory Documentation, and submissions pertaining to, or made in association with, filings with any",
    "bbox": [
      110,
      564,
      1000,
      577
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Governmental Authority, data, including pharmacological, toxicological and clinical data, analytical and quality control data, manufacturing data and",
    "bbox": [
      112,
      581,
      1000,
      591
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "descriptions, patent and legal data, market data, financial data or descriptions, devices, assays, chemical formulations, specifications, material, product",
    "bbox": [
      112,
      597,
      1000,
      607
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "samples and other samples, physical, chemical and biological materials and compounds and information related to such materials and compounds, and",
    "bbox": [
      111,
      611,
      1000,
      623
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "any modifications, improvements, designs, and recipes without regard as to whether any of the foregoing is marked \"confidential' or \"proprietary,\" or",
    "bbox": [
      111,
      627,
      1000,
      640
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "disclosed in oral, written, graphic, or electronic form. Confidential Information shall include the terms and conditions of this Agreement..",
    "bbox": [
      110,
      642,
      1000,
      655
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Source: CYTODYN INC., 10-Q, 1/9/2020",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.20 \"Claim\" has the meaning set forth in Section 13.1..",
    "bbox": [
      111,
      83,
      512,
      94
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.21 \"Clinical Trial' means any human clinical study or trial of a Licensed Product in the Field in the Territory..",
    "bbox": [
      110,
      113,
      917,
      127
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.22 \"Combination Product\"' means a product that is Commercialized by Vyera and/or its Affiliates under this Agreement and that comprises, consists of,",
    "bbox": [
      110,
      145,
      1000,
      157
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "or incorporates two or more APIs (whether administered together or separately), which includes leronlimab as one of the APIs together with one or more",
    "bbox": [
      111,
      161,
      1000,
      173
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "additional APIs that: (a) are not leronlimab; and (b) are not proprietary to CytoDyn, regardless of the formulation or mode of administration of such",
    "bbox": [
      111,
      176,
      1000,
      188
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Combination Product. For the sake of clarity, a Combination Product is a Licensed Product.",
    "bbox": [
      112,
      193,
      770,
      203
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.23 \"Commercial Failure' means that Vyera fails to achieve aggregate [***].",
    "bbox": [
      110,
      221,
      681,
      236
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.24 \"Commercialization' means any and all pre-launch, launch and post-launch activities related to the marketing, promoting, distributing (to Third",
    "bbox": [
      112,
      254,
      1000,
      266
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Parties), offering for sale and selling a Licensed Product in the Field in the Territory. For clarity, Commercialization does not include Development and/or",
    "bbox": [
      111,
      270,
      1000,
      282
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Manufacturing of a Licensed Product. When used as a verb, \"Commercialize\" means to engage in Commercialization..",
    "bbox": [
      111,
      285,
      972,
      297
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.25 \"Commercialization Plan\"' has the meaning set forth in Section 5.2.",
    "bbox": [
      111,
      316,
      638,
      328
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.26 \"Commercially Reasonable Efforts\"' means: (a) with respect to the efforts to be expended, or considerations to be undertaken, by a Party or its",
    "bbox": [
      112,
      348,
      1000,
      358
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Affiliate with respect to any objective, activity or decision to be undertaken hereunder, reasonable, good faith efforts to accomplish such objective,",
    "bbox": [
      112,
      363,
      1000,
      375
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "activity or decision as such Party would normally use to accomplish a similar objective, activity or decision under similar circumstances; and (b) with",
    "bbox": [
      112,
      379,
      1000,
      390
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "respect to Development and Commercialization of any Licensed Product for any indication by a Party, efforts and resources consistent with those efforts",
    "bbox": [
      110,
      393,
      1000,
      406
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "and resources commonly used by a similarly situated biotechnology company with respect to a product owned by it or to which it has similar rights,",
    "bbox": [
      111,
      409,
      1000,
      421
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "which product is at a similar stage in its development or product life and is of similar market potential taking into account (i) the patent and other",
    "bbox": [
      112,
      425,
      1000,
      437
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "proprietary position of the Licensed Product and (ii) the anticipated profitability of the Licensed Product..",
    "bbox": [
      111,
      440,
      875,
      453
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.27 \"Competitive Product' means any product for the treatment or prevention of [***], leronlimab that is not a Licensed Product..",
    "bbox": [
      111,
      471,
      1000,
      483
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "1.28 \"Confidential Information\"' means, subject to Article 10, all non-public or proprietary information not otherwise included in Know-How disclosed by.",
    "bbox": [
      111,
      502,
      1000,
      514
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "either Party to the other Party in connection with the activities contemplated by this Agreement, which may include ideas, inventions, discoveries,",
    "bbox": [
      111,
      518,
      1000,
      530
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "concepts, compounds, compositions, formulations, formulas, practices, procedures, processes, methods, knowledge, know-how, trade secrets,.",
    "bbox": [
      111,
      534,
      1000,
      545
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "technology, inventories, machines, techniques, development, designs, drawings, computer programs, knowledge, skill, experience, documents, apparatus,",
    "bbox": [
      110,
      548,
      1000,
      562
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "results, clinical and regulatory strategies, Regulatory Documentation, and submissions pertaining to, or made in association with, filings with any",
    "bbox": [
      110,
      564,
      1000,
      577
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Governmental Authority, data, including pharmacological, toxicological and clinical data, analytical and quality control data, manufacturing data and",
    "bbox": [
      112,
      581,
      1000,
      591
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "descriptions, patent and legal data, market data, financial data or descriptions, devices, assays, chemical formulations, specifications, material, product",
    "bbox": [
      112,
      597,
      1000,
      607
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "samples and other samples, physical, chemical and biological materials and compounds and information related to such materials and compounds, and",
    "bbox": [
      111,
      611,
      1000,
      623
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "any modifications, improvements, designs, and recipes without regard as to whether any of the foregoing is marked \"confidential' or \"proprietary,\" or",
    "bbox": [
      111,
      627,
      1000,
      640
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "disclosed in oral, written, graphic, or electronic form. Confidential Information shall include the terms and conditions of this Agreement..",
    "bbox": [
      110,
      642,
      1000,
      655
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  },
  {
    "text": "Source: CYTODYN INC., 10-Q, 1/9/2020",
    "bbox": [
      133,
      1000,
      451,
      1000
    ],
    "label": 39,
    "category": "Covenant Not To Sue"
  }
]